Pfizer (PFE) reported Q4 FY 2019 earnings of $0.55 per share (versus $0.64 per share in Q4 FY 2018), missing analysts' consensus estimate of $0.58 per share.
The company's quarterly revenues amounted to $12.688 bln (-9.2% y/y), roughly in line with analysts' consensus estimate of $12.728 bln.
The company also issued guidance for FY 2020, projecting EPS of $2.82-$2.92 (versus analysts' consensus estimate of $2.82) and revenues of $48.5-$50.5 bln (versus analysts' consensus estimate of $48.93 bln).
PFE fell to $39.40 (-1.89%) in pre-market trading.